Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Dexfenfluramine

3

VI.b Pulmonary arterial hypertension

1
Last update : 26/01/2013
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Aminorex
5
Amphetamine (and -derivatives)
3
Cocaine
5
Fenfluramine
3
Levamisole
4

Publications

Pulmonary arterial hypertension in a patient with Cowden syndrome and anorexigen exposure.
Chest 2011 Oct;140;1066-1068 2011 Oct
Benfluorex and unexplained valvular heart disease: a case-control study.
PloS one 2010 Apr 12;5;e10128 2010 Apr 12
Fenfluramine-like cardiovascular side-effects of benfluorex.
The European respiratory journal 2009 Mar;33;684-8 2009 Mar
Aminorex, dexfenfluramine, and primary pulmonary hypertension.
Journal of clinical epidemiology 1998 Apr;51;361-4 1998 Apr
Pulmonary hypertension and dexfenfluramine.
Lancet (London, England) 1992 Feb 15;339;436 1992 Feb 15

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies